Balaxi Pharmaceuticals Limited (NSEI: BALAXI)
Health Care · Health Care Providers & Services · IN
Rs22.40
-6.67% today · -52.2% 1Y
Balaxi Pharmaceuticals Limited (NSEI: BALAXI) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $12.92M and employs 51 people.
Over the last twelve months the share price has lost 52.2%, trading between 15.20 and 49.23.
Tweenvest scores Balaxi Pharmaceuticals Limited across four factors: quality 59/100, value 46/100, growth 42/100. Its strongest factor is quality.
BALAXI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.92M
- Revenue (TTM)
- $29.63M
- P/E
- 50.10
- EPS
- 0.45
- Dividend yield
- —
- Beta (5Y)
- 0.73
- 52-week high
- Rs49.23
- 52-week low
- Rs15.20
- Avg volume (3M)
- —
- Shares outstanding
- 55.21M
- Employees
- 51
- Next earnings
- —
About Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited, through its entity Balaxi Ventures Ltd., primarily operates as an international wholesale distributor specializing in pharmaceuticals, various food items, and hardware supplies. The company's corporate base is situated in Hyderabad, Telangana. Its extensive product range features pharmaceutical formulations, a variety of food products, and construction-related hardware. Notably, both its pharmaceutical and builders' hardware offerings are manufactured under contract at different plants located across India. Within its food segment, the firm markets a selection of food and biscuit products under the recognizable brand name YAP. Balaxi Global DMCC is among the key subsidiaries within the company's structure.
- ISIN
- INE618N01022
- Founded
- 1942
- Listed since
- Dec 2, 2015
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $391.59 | +0.38% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.11 | +0.10% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $320.72 | +0.84% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.